PS
Prashant Singh
About Prashant Singh
Data last updated:
Prashant Singh is a Director at Wilburt Remedies Private Limited (since 2014), Director at Wilshire Pharmaceuticals Private Limited (since 2012) and Director at Willcare Lifesciences Private Limited (since 2012), and holds 1 more current directorship. The companies operate in Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹46.84 Cr; the largest is Wilburt Remedies Private Limited at ₹18.35 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wilburt Remedies Private Limited U24232MP2012PTC028524 | Director | 11 Jul 2014 | 2012 | ₹18.35 Cr (FY 2023) | Active |
 Wilshire Pharmaceuticals Private Limited U24232MP2010PTC024287 | Director | 23 Mar 2012 | 2010 | ₹15.58 Cr (FY 2023) | Active |
 Willcare Lifesciences Private Limited U24232MP2011PTC025624 | Director | 15 Nov 2012 | 2011 | ₹12.91 Cr (FY 2025) | Active |
 Xenex Therapeutics Llp ACJ-6497 | Designated Partner | 27 Sep 2024 | 2024 | Active |
Board colleagues of Prashant Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharamveer Singh Shaktawat | 06923143 | Wilburt Remedies Private Limited | Director |
| Pramod Patil | 03146744 | Wilburt Remedies Private Limited , Wilshire Pharmaceuticals Private Limited | Director |
| Rajesh Jat | 03146756 | Wilburt Remedies Private Limited , Wilshire Pharmaceuticals Private Limited and 1 more | Director |
| Mohd Arif Siddique | 03136684 | Wilshire Pharmaceuticals Private Limited | Director |
| Mohd Kamil Shah | 03343494 | Wilshire Pharmaceuticals Private Limited | Director |
| Gururaj Patil | 11338821 | Willcare Lifesciences Private Limited | Additional Director |
| Prashant Srikanti | 03535756 | Willcare Lifesciences Private Limited , Xenex Therapeutics Llp | Director |
| Ravi Sood | 03619759 | Willcare Lifesciences Private Limited | Director |
| Shashank Bajpai | 06437181 | Willcare Lifesciences Private Limited , Xenex Therapeutics Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prashant Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prashant Singh
Prashant Singh currently holds 4 directorships: Wilburt Remedies Private Limited (Director, since 11 Jul 2014, revenue ₹18.35 Cr (FY 2023)); Wilshire Pharmaceuticals Private Limited (Director, since 23 Mar 2012, revenue ₹15.58 Cr (FY 2023)); Willcare Lifesciences Private Limited (Director, since 15 Nov 2012, revenue ₹12.91 Cr (FY 2025)); Xenex Therapeutics Llp (Designated Partner, since 27 Sep 2024).
Prashant Singh was first appointed on 23 Mar 2012 as Director at Wilshire Pharmaceuticals Private Limited. The most recent appointment on record is 27 Sep 2024 at Xenex Therapeutics Llp.
The 3 current companies of Prashant Singh that report revenue have a combined latest revenue of ₹46.84 Cr: Wilburt Remedies Private Limited ₹18.35 Cr (FY 2023); Wilshire Pharmaceuticals Private Limited ₹15.58 Cr (FY 2023); Willcare Lifesciences Private Limited ₹12.91 Cr (FY 2025).
The current boards of Prashant Singh's companies include Dharamveer Singh Shaktawat (Wilburt Remedies Private Limited), Pramod Patil (Wilburt Remedies Private Limited), Rajesh Jat (Wilburt Remedies Private Limited), Mohd Arif Siddique (Wilshire Pharmaceuticals Private Limited), Mohd Kamil Shah (Wilshire Pharmaceuticals Private Limited), Gururaj Patil (Willcare Lifesciences Private Limited), among others.